Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Could a 100-year-old TB vaccine help scientists find a better one?
Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis
Study points toward progress on TB vaccines
High-tech analysis of correlates of protection may improve 100-year-old vaccine strategy
An old HIV vaccine surprises researchers once again
Designed for a Thailand strain of the AIDS virus, it stirred stronger immunity in South Africa
With Fred Hutch's HIV lab in South Africa, 'We've become full partners.'
An HIV laboratory in South Africa advances scientific understanding, and more
International AIDS Conference: Where we’ve been, what’s next in the quest to end HIV
The last time the International AIDS Conference was in Africa, AIDS denialism was at its height; two Fred Hutch leaders in the fight to end HIV talk about where we’ve been – and what’s next
‘Don’t stop now’: an endgame for HIV/AIDS
HBO’s ‘Countdown to Zero,’ featuring Fred Hutch researchers, shows the pandemic remains, but fresh hope abounds
Countdown to Zero: The path to an HIV vaccine
A World AIDS Day Q&A with Fred Hutch’s Dr. Larry Corey, featured in HBO special report
HIV Vaccine Trials Network among five nationwide selected to receive seven-year award - Fred Hutchinson Cancer Research Center
NIH funding will propel large-scale HIV vaccine clinical trials in South Africa and beyond
Traditional healers play key role in fighting AIDS in South Africa
Healers act as ‘first level of community health care,’ bridge HVTN sites with surrounding areas
Cape Town conference ends, 'grand endeavor' begins
Week-long meeting, lab opening mark start of journey toward successful HIV vaccine, said Dr. Larry Corey
'I'm passionate about helping': Up close with an HIV vaccine trial participant
One South African woman explains why she volunteered for a vaccine being tested by HVTN
'This is about survival': Hutch opens Cape Town Lab to move HIV vaccine forward
Ribbon cutting ceremony marks the official opening of the Cape Town Immunology Laboratory
Fred Hutchinson Cancer Research Center opens HIV-vaccine lab in South Africa - Fred Hutchinson Cancer Research Center
Cape Town facility is integral in the effort to stop the global spread of AIDS
'Never give up': Researchers' tireless quest for HIV vaccines leads to Cape Town
HIV Vaccine Trials Network opens South African lab as it gears up to launch
Fighting HIV on its own turf
Fred Hutch is opening a Cape Town lab to launch HIV vaccine trials in South Africa, where the virus has infected more people than in any other country
Fred Hutch-affiliated clinical researcher receives South Africa's highest civilian award
HIV Vaccine Trials Network's Africa Programs Director Glenda Gray lauded for lifesaving HIV/AIDS work